A pH-responsive liposomal nanoplatform for co-delivery of a Pt(IV) prodrug and cinnamaldehyde for effective tumor therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Ting,Tang ^[1] ; Yufang,Gong ^[2] ; Yuan,Gao ^[2] ; Xinlong,Pang ^[2] ; Shuangqing,Liu ^[2] ; Yulan,Xia ^[1] ; Dongsheng,Liu ^[1] ; Lin,Zhu ^[1] ; Qing,Fan ^[2] ; Xiao,Sun ^[2]

作者单位： Department of Dental Implantology, Hefei Stomatology Hospital, Clinical School of Anhui Medical University, Hefei, China. ^[1] Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. ^[2]

关键词 Pt(IV) prodrug cinnamaldehyde liposome reactive oxygen species tumor synergistic therapy

DOI 10.3389/fbioe.2023.1191534

PMID 37214306

发布时间 2023-05-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in bioengineering and biotechnology

2023年11卷

1191534页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A pH-responsive liposomal nanoplatform for co-delivery of a Pt(IV) prodrug and cinnamaldehyde for effective tumor therapy.

Frontiers in bioengineering and biotechnology

相似文献

Frontiers in bioengineering and biotechnology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A pH-responsive liposomal nanoplatform for co-delivery of a Pt(IV) prodrug and cinnamaldehyde for effective tumor therapy.

Frontiers in bioengineering and biotechnology

相似文献

Frontiers in bioengineering and biotechnology

相关期刊

检索历史清除